Amy H.

Amy H. is a seasoned professional in medical writing and clinical research, currently serving as Senior Director of Medical Writing at Morphic Therapeutic since August 2023. Prior roles include Senior Director of Medical Writing at Nuvation Bio and Director of Medical Writing at Ultragenyx Pharmaceutical Inc. Additional experience encompasses leadership positions in medical writing at Unum Therapeutics and Keryx Biopharmaceuticals, as well as progressive roles at Millennium, Takeda, and Millennium Pharmaceuticals. Earlier in the career, Amy H. worked as a Senior Clinical Research Associate at Millennium Pharmaceuticals and held positions in clinical research at Wyeth Research and Diacrin, Inc. The educational background includes a Master of Science in Entomology from Washington State University and a Bachelor of Science in Biology from Tufts University.